Abbrea Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$269K Hold
1,367
0.04% 199
2024
Q1
$294K Hold
1,367
0.04% 212
2023
Q4
$295K Hold
1,367
0.04% 202
2023
Q3
$274K Hold
1,367
0.04% 201
2023
Q2
$253K Buy
1,367
+45
+3% +$8.32K 0.04% 213
2023
Q1
$253K Hold
1,322
0.04% 205
2022
Q4
$228K Sell
1,322
-40
-3% -$6.95K 0.04% 213
2022
Q3
$241K Hold
1,362
0.05% 199
2022
Q2
$279K Buy
1,362
+75
+6% +$15.9K 0.05% 194
2022
Q1
$306K Hold
1,287
0.04% 206
2021
Q4
$298K Buy
1,287
+102
+9% +$22.4K 0.04% 209
2021
Q3
$229K Buy
+1,185
New +$240K 0.03% 228

Other funds holding CME

Abbrea Capital's CME Position: Q2 2024 in Review

Abbrea Capital held its CME Group (CME) position steady in Q2 2024 at 1,367 shares worth $269K. The position accounts for 0.04% of the portfolio, ranked #199.

Abbrea Capital first reported a position in CME in Q3 2021 and has held it in 12 quarters since. The position peaked at $306K in Q1 2022. 1,382 funds tracked by Wall St. Rank hold CME as of Q2 2024.

  • Abbrea Capital held 1,367 shares of CME Group worth $269K as of Q2 2024.
  • Abbrea Capital left its CME Group share count unchanged in Q2 2024.
  • CME Group made up 0.04% of Abbrea Capital's portfolio in Q2 2024, its #199 holding.
  • Abbrea Capital first reported a position in CME Group in Q3 2021 and has held it in 12 quarters since.
  • Abbrea Capital's CME Group position peaked at $306K in Q1 2022.
  • 1,382 funds tracked by Wall St. Rank held CME Group as of Q2 2024.

Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.